Hernández-Mendoza M, Vargas-Jimenez E, Alcántara-González LG, Flores-Cruz U, Uribe-Vázquez Y, Ávila-Pérez JR, Cabañas-Monter AJ

Language: Spanish
References: 20
Page: 53-58
PDF size: 218.26 Kb.

ABSTRACT

Objective: to analyze the reduction of body weight and the modification of anthropometric and biochemical parameters of the beneficiaries enrolled in the “Pierde Kilos, Gana Vida” program. Methods: cross-sectional analytical study carried out at the General Zone Hospital with Family Medicine No. 1 of the Mexican Institute of Social Security (IMMS) in Pachuca, Hidalgo. Eighty-three records were reviewed in the database of the aforementioned program, obtained by non-probabilistic convenience sampling, with the following selection criteria: records of patients over 18 years of age, with a diagnosis of overweight and obesity. The study variables were weight, abdominal perimeter, body mass index (BMI), glucose, cholesterol and triglyceride levels at program entry and exit. Inferential statistics were performed with Student’s t and Wilcoxon statistical tests, a value of p‹0.05 was considered statistically significant. Results: 78.3% of the participants reduced an average of 3.204 kg (3.81%) of body weight (p= 0.000). 69.88% reduced abdominal perimeter by an average of 5.29 cm (4.51%) (p= 0.000). While 2.41% managed to change their nutritional status to normal weight. More than 50% decreased their glucose, cholesterol and triglyceride levels (p‹0.05). Conclusion: the “Lose Weight, Gain Life” program generated significant reductions in weight, abdominal perimeter, BMI and biochemical levels in several participants. Although important results were achieved, there is room for improvement, especially in terms of compliance with program objectives and long-term follow-up.

REFERENCES

1. Blüher M. Obesity: global epidemiologyand pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-98.

2. OMS. Obesidad y sobrepeso [Internet]. [citado2024 May 29]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/obesity-andoverweight

3. NCD Risk Factor Collaboration (NCD-RisC).Trends in adult body-mass index in 200 countriesfrom 1975 to 2014: a pooled analysis of 1698population-based measurement studies with 19·2million participants. 2016;387(10026):1377-96.

4. Shamah-Levy T, Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-ArredondoS, Colchero MA, y cols. Encuesta Nacionalde Salud y Nutrición 2021 sobre Covid-19.Resultados nacionales. Cuernavaca, México: InstitutoNacional de Salud Pública; 2022.

5. Instituto Mexicano del Seguro Social. Atenciónde la obesidad comienza con el control del pesoy una revisión periódica sobre el estado de salud.2020 [Internet]. [citado 2024 May 29]. Disponibleen: https://www.imss.gob.mx/prensa/archivo/202002/059

6. Instituto Nacional de Salud Pública. México y laspolíticas públicas ante la obesidad [Internet]. [citado2024 May 30]. Disponible en: https://www.insp.mx/avisos/5091-dia-mundial-obesidad-politicas.html

7. Wharton S, Lau DCW, Vallis M, Sharma AM,Biertho L, Campbell-Scherer D, et al. Obesityin adults: a clinical practice guideline. CMAJ.2020;192(31):E875-E891.

8. Instituto Mexicano del Seguro Social. LineamientosPrograma “Pierde kilos, Gana Vida”,2021 [Internet]. [citado 2024 May 29]. Disponibleen: https://www.imss.gob.mx/prensa/archivo/202211/583.

9. Secretaría de Salud. NORMA Oficial MexicanaNOM-008-SSA3-2010, Para el tratamiento integraldel sobrepeso y la obesidad [Internet]. [citado2024 May 28]. Disponible en: https://www.dof.gob.mx/normasOficiales/4127/Salud/Salud.htm.

10. Ramírez RA, Polack PAM. Estadística inferencial.Elección de una prueba estadística no paramétricaen investigación científica. Horizonte de la Ciencia.2020;10(19):191-208.

11. Kain ZN, MacLaren J. Valor de p inferior a0,05: ¿qué significa en realidad? Pediatrics.2007;63(3)118-20.

12. Rubio HMA, Moreno LC. Medicina basada en laevidencia: nutrición en la obesidad. EndocrinolNutr. 2005;52(Supl 2):102-9.

13. Kaufer-Horwitz M, Pérez HJF. La obesidad: aspectosfisiopatológicos y clínicos. Inter Disciplina.2022;10(26):147.

14. Álvarez-Álvarez L, Rubín-García M, Vitelli StorelliF, Fernández-Vázquez JP, Basora J, Fitó M. Efectode una intervención nutricional intensiva enpacientes refractarios a la pérdida de peso. MedFam SEMERGEN. 2020;46(3):167-74.

15. Terapia nutricional médica para la diabetes mellitustipo 2. [Internet]. [citado 29 mayo24], Disponibleen: https://www.uptodate.com/contents/medical-nutrition-therapy-for-type-2-diabetesmellitus

16. Andrews RC, Cooper AR, Montgomery AA, NorcrossAJ, Peters TJ, Sharp DJ, et al. Diet or dietplus physical activity versus usual care in patientswith newly diagnosed type 2 diabetes: the EarlyACTID randomised controlled trial. The Lancet.2011;378(9786):129-39.

17. UK Prospective Diabetes Study 7: response of fastingplasma glucose to diet therapy in newly presentingtype II diabetic patients, UKPDS Group.Metabolism. 1990;39(9):905-12.

18. Coppell KJ, Kataoka M, Williams SM, ChisholmAW, Vorgers SM, Mann JI. Nutritional interventionin patients with type 2 diabetes who arehyperglycaemic despite optimised drug treatment--Lifestyle Over and Above Drugs in Diabetes(LOADD) study: randomised controlled trial.BMJ. 2010;341:c3337

19. Evert AB, Dennison M, Gardner CD, Garvey WT,Lau KHK, MacLeod J, et al. Nutrition Therapy forAdults with Diabetes or Prediabetes: A ConsensusReport. Diabetes Care. 2019;42(5):731-54.

20. Gudzune KA, Doshi RS, Mehta AK, ChaudhryZW, Jacobs DK, Vakil RM, Lee CJ, Bleich SN,Clark JM. Efficacy of commercial weight-loss programs:an updated systematic review. Ann InternMed. 2015 Apr 7;162(7):501-512.